---
title: "Sinomab Bio hits 52-week low"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305430105.md"
description: "Sinomab Bio fell 4.50% to HK$0.9550. Down 10.75% over ten sessions and down 28.73% YTD."
datetime: "2026-11-13T07:59:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305430105.md)
  - [en](https://longbridge.com/en/news/305430105.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305430105.md)
generator: "portal-rs"
---

# Sinomab Bio hits 52-week low

Sinomab Bio (3681.HK) fell nearly **5%** in Hong Kong trading to **HK$0.9550**, hitting a 52-week low intraday.

The stock is down 10.75% over the past ten sessions and down 28.73% year to date. It sits 56.39% below its 52-week high of HK$2.190. Volume was 0.31 times its average.

The Hang Seng Index is down 3.48% over the past five sessions and down 7.80% year to date.

The biotechnology industry index fell 3.0% over the same period, in line with the stock's move.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [03681.HK](https://longbridge.com/en/quote/03681.HK.md)

## Related News & Research

- [SinoMab BioScience held shareholder meeting, disposal resolution drew 100% support](https://longbridge.com/en/news/298192293.md)
- [SinoMab BioScience announces extraordinary general meeting](https://longbridge.com/en/news/296540884.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [Moonshot drops $150M Indonesia Nvidia rental days after US loophole crackdown](https://longbridge.com/en/news/306145817.md)
- [PRESS DIGEST-New York Times business news - November 20](https://longbridge.com/en/news/306242079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**